Department of Obstetrics and Gynecology, Baskent University School of Medicine, Ankara, Turkey.
Int J Gynecol Cancer. 2012 Sep;22(7):1198-202. doi: 10.1097/IGC.0b013e31825e0d5a.
To report a triplet pregnancy complicated by clear cell cervical carcinoma that was managed using neoadjuvant chemotherapy followed by caesarean radical hysterectomy.
A 26-year-old woman had a diagnosis of cervical clear cell carcinoma, which was International Federation of Gynecology and Obstetrics stage IB1, at 18 weeks of gestation during a triplet pregnancy. Owing to the patient's strong desire for full-term pregnancy, 3 cycles of neoadjuvant chemotherapy was administered after magnetic resonance imaging evaluation of the tumor. The patient underwent cesarean delivery and radical hysterectomy at gestational week 32. The hysterectomy specimen revealed stage IB1 clear cell adenocarcinoma of the cervix. The neonates and the mother did not have any complications related to the treatment during 36 months of follow-up.
To the best of our knowledge, this is the first report of a triplet pregnancy complicated by cervical clear cell carcinoma that was successfully treated with neoadjuvant chemotherapy and cesarean radical hysterectomy. Our experience and literature review suggest that neoadjuvant chemotherapy for cervical carcinoma diagnosed during pregnancy is associated with excellent oncologic and fetal outcome; therefore, it may be considered as a temporary fertility-sparing approach in selected patients with a strong desire for full-term pregnancy. Nonetheless, additional research and long-term follow-up are needed to reach a more definitive conclusion.
报告一例妊娠三胞胎并发宫颈透明细胞癌,采用新辅助化疗后行剖宫产根治性子宫切除术治疗。
1 名 26 岁女性,妊娠 18 周时被诊断为宫颈透明细胞癌,国际妇产科联合会(FIGO)分期为 IB1 期。由于患者强烈希望足月妊娠,在肿瘤磁共振成像评估后接受了 3 个周期的新辅助化疗。患者在妊娠 32 周时行剖宫产和根治性子宫切除术。子宫切除标本显示宫颈 IB1 期透明细胞腺癌。在 36 个月的随访中,新生儿和母亲均未出现与治疗相关的并发症。
据我们所知,这是首例妊娠三胞胎并发宫颈透明细胞癌,经新辅助化疗和剖宫产根治性子宫切除术成功治疗的病例报告。我们的经验和文献复习表明,妊娠期间诊断的宫颈癌新辅助化疗具有良好的肿瘤学和胎儿结局,因此,对于强烈希望足月妊娠的特定患者,可能可以考虑作为一种暂时保留生育能力的方法。然而,需要进一步的研究和长期随访以得出更明确的结论。